Diabetes Panel 2 Essential Blood Urine Test

This test measures glucose concentration in peritoneal dialysate fluid, the solution used during peritoneal dialysis for kidney failure. Glucose naturally diffuses from the dialysate into the bloodstream during treatment, and measuring residual glucose helps assess dialysate dwell time and treatment effectiveness. Changes in dialysate glucose levels can indicate peritoneal membrane changes or absorption problems affecting dialysis adequacy and treatment outcomes.

This test measures blood glucose at 4 PM, capturing your blood sugar level in the afternoon hours rather than fasting. It helps assess how your body is managing glucose throughout the day and identifies post-meal blood sugar patterns. Elevated afternoon glucose can indicate poor glucose control, insulin resistance, or undiagnosed diabetes. This measurement is particularly useful for monitoring metabolic health in individuals with irregular eating patterns or those already diagnosed with blood sugar disorders.

Glucose measured at 5 PM captures blood sugar levels in the late afternoon, often used to assess post-lunch or afternoon metabolism patterns. This timed glucose test helps evaluate glucose control throughout the day and may identify afternoon energy dips. Results are useful when screening for metabolic disorders or monitoring diabetes management at specific times.

This glucose test measures blood sugar levels before taking a medication dose, typically used in diabetes management to assess how well glucose control is maintained throughout the day. Pre-dose glucose readings help clinicians evaluate whether current medication doses are effective or need adjustment. These measurements are particularly valuable for patients on insulin or other glucose-lowering medications, as they reveal patterns in blood sugar levels and guide treatment modifications to achieve optimal metabolic control.

This test measures blood glucose after a fasting period, typically 8-12 hours without food or drink. Fasting glucose is a fundamental screening tool for metabolic disorders including diabetes and prediabetes. Normal fasting glucose ranges from 70-100 mg/dL; levels 100-125 mg/dL suggest prediabetes, and values above 126 mg/dL indicate diabetes. Fasting glucose is less affected by recent meals than non-fasting measurements, providing a stable baseline for assessing long-term glucose control and metabolic health.

Proinsulin is the inactive precursor molecule from which insulin is formed in the pancreas. A blood proinsulin test measures levels of this compound, which is a sensitive marker of beta cell stress and insulin resistance. Elevated fasting proinsulin—even with normal insulin and glucose levels—suggests early pancreatic dysfunction and may predict future diabetes development. This test is useful for identifying individuals at high risk for type 2 diabetes before standard tests become abnormal, enabling early intervention through lifestyle changes.

Insulin is a hormone produced by the pancreas that regulates blood glucose levels by allowing cells to absorb sugar for energy. An insulin test measures circulating insulin levels, which rise after eating or during fasting depending on metabolic function. Elevated fasting insulin may indicate insulin resistance, where cells don't respond properly to insulin, increasing risk for prediabetes and metabolic syndrome. Low insulin levels may suggest pancreatic dysfunction or diabetes.

This test detects antibodies against insulin, which can develop in response to insulin therapy or, in some cases, spontaneously. Insulin antibodies may reduce insulin effectiveness, requiring higher doses. In type 1 diabetes, insulin autoantibodies (detected before symptom onset) are predictive of disease development. This test is used to screen for type 1 diabetes risk in relatives of affected individuals and to investigate inadequate response to insulin therapy. Results help guide treatment decisions.

This test measures blood glucose 1 hour after consuming 50 grams of glucose, a simplified screening test for gestational diabetes and glucose intolerance. Unlike the standard glucose tolerance test, this does not require fasting and is more convenient for screening. Elevated glucose after the glucose challenge suggests impaired glucose handling and increased diabetes risk. This test is commonly performed during pregnancy (typically between 24-28 weeks) to screen for gestational diabetes, which affects maternal and fetal health. Abnormal results warrant a full diagnostic glucose tolerance test.

Hemoglobin A1c measures the percentage of hemoglobin (in red blood cells) that has glucose attached to it. Since red blood cells live about 3 months, HbA1c reflects your average blood glucose over the past 2-3 months. Unlike a single fasting glucose test, HbA1c provides a comprehensive picture of long-term glucose control. It's the gold standard for diagnosing and monitoring diabetes, and elevated levels indicate prediabetes or diabetes.